Weiss Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,350
Closed -$403K 395
2022
Q4
$403K Buy
+28,350
New +$411K 0.02% 380
2022
Q1
Sell
-19,624
Closed -$377K 833
2021
Q4
$377K Buy
+19,624
New +$395K 0.01% 568
2019
Q2
Sell
-23,143
Closed -$396K 381
2019
Q1
$396K Sell
23,143
-7,682
-25% -$133K 0.03% 127
2018
Q4
$466K Buy
+30,825
New +$543K 0.03% 220
2018
Q1
Sell
-18,876
Closed -$371K 277
2017
Q4
$371K Buy
+18,876
New +$378K 0.03% 146
2017
Q1
Sell
-12,538
Closed -$213K 134
2016
Q4
$213K Buy
+12,538
New +$220K 0.03% 128
2016
Q1
Sell
-10,036
Closed -$237K 143
2015
Q4
$237K Buy
+10,036
New +$249K 0.06% 175
2014
Q3
Sell
-108,203
Closed -$2.25M 44
2014
Q2
$2.25M Buy
+108,203
New +$2.27M 1.55% 14

Other funds holding HQL

Weiss Asset Management's HQL Position: Q1 2023 in Review

Weiss Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q1 2023, closing a stake of 28,350 shares — an estimated $403K sold.

Weiss Asset Management first reported a position in HQL in Q2 2014 and held it in 8 quarters. The position peaked at $2.25M in Q2 2014. 78 funds tracked by Wall St. Rank hold HQL as of Q1 2023.

  • Weiss Asset Management reported no remaining abrdn Life Sciences Investors position as of Q1 2023 after selling out during the quarter.
  • Weiss Asset Management sold 28,350 abrdn Life Sciences Investors shares in Q1 2023, an estimated $403K.
  • Weiss Asset Management first reported a position in abrdn Life Sciences Investors in Q2 2014 and held it in 8 quarters.
  • Weiss Asset Management's abrdn Life Sciences Investors position peaked at $2.25M in Q2 2014.
  • 78 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2023.

Based on Weiss Asset Management's 13F filing for Q1 2023, filed 10 May 2023.